Skip to main content
Livermore
Livermore
ZHEN

Celcuity Inc.

CELC
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001603454

In the last 90 days, Celcuity Inc. insiders filed 0 open-market purchases and 1 sale; 273 institutions reported holding it in 13F filings for Q2 2026, worth $5.95B in total; no superinvestor holds it.

Holders of 5% or more of CELC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Celcuity Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CELC
HolderLatest formStakeChangeFirst filedLatest filingFiling
Baker Bros. Advisors LP13G9.99%4.88M shares0.00 ppfrom 9.99%Nov 14, 20247 filingsJul 16, 2026SEC
Soleus Capital Master Fund, L.P.13G/A9.90%3.87M shares–May 18, 20224 filingsFeb 11, 2025SEC
Sullivan Brian F.13G/A9.10%4.01M shares–Feb 12, 20215 filingsNov 13, 2025SEC
Perceptive Advisors LLC13G/A6.80%3.16M shares+0.25 ppfrom 6.55%Dec 26, 20236 filingsFeb 17, 2026SEC
Avoro Capital Advisors LLC13G6.72%3.11M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
Bank of America Corp13G6.50%3.17M sharesNewAug 11, 20261 filingAug 11, 2026SEC
RTW Investments, LP13G6.30%3.04M sharesNewMay 15, 20261 filingMay 15, 2026SEC
BlackRock, Inc.13G5.90%2.18M sharesNewFeb 4, 20251 filingFeb 4, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

59 Schedule 13D and 13G filings on Celcuity Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CELC
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 11, 20263:41 PM ETBank of America Corp13G6.50%3.17M sharesNewJun 30, 2026SEC
Jul 16, 20265:57 PM ETBaker Bros. Advisors LPand 3 others13G9.99%4.88M shares0.00 ppfrom 9.99%Jul 14, 2026SEC
Jul 16, 20265:51 PM ETBaker Bros. Advisors LPand 3 others13D/A9.99%4.88M shares−10.00 ppfrom 19.99%Jul 14, 2026SEC
May 15, 20268:12 AM ETRTW Investments, LPand 1 other13G6.30%3.04M sharesNewMar 31, 2026SEC
Mar 24, 20264:06 PM ETBaker Bros. Advisors LPand 3 others13D/A19.99%9.58M shares+1.09 ppfrom 18.90%Mar 20, 2026SEC
Mar 9, 20267:17 PM ETGrowth Equity Opportunities 18 VGE, LLCand 11 others13D/A4.90%2.29M shares−1.40 ppfrom 6.30%Below 5%Mar 5, 2026SEC
Feb 17, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A6.80%3.16M shares+0.25 ppfrom 6.55%Dec 31, 2025SEC
Feb 17, 20269:02 AM ETAvoro Capital Advisors LLCand 1 other13G6.72%3.11M sharesNewDec 31, 2025SEC
Feb 12, 20265:00 PM ETSoleus Private Equity Fund II, L.P.and 8 others13G/A3.90%1.81M shares–Below 5%Dec 31, 2025SEC
Jan 16, 20265:30 PM ETGrowth Equity Opportunities 18 VGE, LLCand 11 others13D/A6.30%2.91M shares−1.80 ppfrom 8.10%Jan 14, 2026SEC
Nov 14, 20254:06 PM ETBiotechnology Value Fund L Pand 9 others13G/A1.60%658.4K shares–Below 5%Sep 30, 2025SEC
Nov 13, 20255:33 PM ETSullivan Brian F.13G/A9.10%4.01M shares–Sep 30, 2025SEC
Nov 13, 20255:30 PM ETLaing Lance G.13G/A3.60%1.57M shares–Below 5%Sep 30, 2025SEC
Aug 18, 20256:02 PM ETGrowth Equity Opportunities 18 VGE, LLCand 13 others13D/A8.10%3.54M shares–Aug 14, 2025SEC
Aug 4, 20255:46 PM ETPerceptive Advisors LLCand 2 others13G6.55%2.67M shares+2.24 ppfrom 4.31%Jul 30, 2025SEC
Aug 4, 20255:44 PM ETPerceptive Advisors LLCand 2 others13G/A4.31%1.63M shares−2.09 ppfrom 6.40%Below 5%Jun 30, 2025SEC
Aug 1, 20255:41 PM ETBaker Bros. Advisors LPand 3 others13D18.90%7.75M shares+7.60 ppfrom 11.30%Aug 1, 2025SEC
Apr 7, 20257:04 PM ETBaker Bros. Advisors LPand 3 others13G/A11.30%4.26M shares+4.10 ppfrom 7.20%Mar 31, 2025SEC
Feb 14, 20255:14 PM ETCommodore Capital LPand 1 other13G/A2.90%1.10M shares–Below 5%Dec 31, 2024SEC
Feb 14, 20254:15 PM ETBaker Bros. Advisors LPand 3 others13G/A7.20%2.68M shares–Dec 31, 2024SEC
Feb 14, 20254:15 PM ETPerceptive Advisors LLCand 2 others13G/A6.40%2.36M shares–Dec 31, 2024SEC
Feb 11, 20254:00 PM ETSoleus Capital Master Fund, L.P.and 8 others13G/A9.90%3.87M shares–Dec 31, 2024SEC
Feb 4, 20253:45 PM ETBlackRock, Inc.13G5.90%2.18M sharesNewDec 31, 2024SEC
Nov 14, 2024Commodore Capital LP13G/AOld format–––SEC
Nov 14, 2024Soleus Private Equity Fund II, L.P.13G/AOld format–––SEC
Nov 14, 2024Venrock Healthcare Capital Partners III, L.P.13G/AOld format–––SEC
Nov 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Nov 14, 2024Baker Bros. Advisors LP13GOld format–New–SEC
Oct 7, 2024Morgan Stanley13G/AOld format–––SEC
Jun 10, 2024Biotechnology Value Fund L P13GOld format–New–SEC
Feb 14, 2024Commodore Capital LP13G/AOld format–––SEC
Feb 14, 2024Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2024Venrock Healthcare Capital Partners III, L.P.13G/AOld format–––SEC
Feb 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 12, 2024Morgan Stanley13G/AOld format–––SEC
Feb 9, 2024Soleus Capital Master Fund, L.P.13G/AOld format–––SEC
Feb 7, 2024Laing Lance G.13G/AOld format–––SEC
Feb 7, 2024Sullivan Brian F.13G/AOld format–––SEC
Dec 26, 2023Perceptive Advisors LLC13GOld format–New–SEC
Feb 14, 2023Commodore Capital LP13G/AOld format–––SEC
Feb 14, 2023Soleus Capital Master Fund, L.P.13G/AOld format–––SEC
Feb 14, 2023Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2023Venrock Healthcare Capital Partners II, L.P.13G/AOld format–––SEC
Feb 8, 2023Morgan Stanley13GOld format–New–SEC
Feb 2, 2023Sullivan Brian F.13G/AOld format–––SEC
Feb 2, 2023Laing Lance G.13G/AOld format–––SEC
Sep 12, 2022Growth Equity Opportunities 18 VGE, LLC13D/AOld format–––SEC
May 25, 2022Venrock Healthcare Capital Partners II, L.P.13GOld format–New–SEC
May 25, 2022Ra Capital Management, L.P.13GOld format–New–SEC
May 24, 2022Growth Equity Opportunities 18 VGE, LLC13DOld format–New–SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Celcuity Inc. shares, newest first.

Form 144 notices for CELC
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 23, 20231:07 PM ETBuller Richard EDirector600$7.07KJun 23, 202310b5-1THE CHARLES SCHWAB CORPORATIONSEC